Latest News about DNLI
Recent news which mentions DNLI
Denali Therapeutics Stock Is Sliding After The Bell: Here's Why
October 10, 2024
From Benzinga
DNLI Stock Earnings: Denali Therapeutics Beats EPS for Q2 2024
August 01, 2024
Tickers
DNLI
From InvestorPlace
3 Longevity Stocks to Buy for Anti-Aging Breakthroughs
July 08, 2024
From InvestorPlace
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
June 03, 2024
From Benzinga
From Benzinga
Tickers
DNLI
From InvestorPlace
To the Moon and Beyond: 7 Stocks With Cosmic Potential
March 14, 2024
From InvestorPlace
Goldman Sachs Maintains Buy Rating for Denali Therapeutics: Here's What You Need To Know
February 29, 2024
Tickers
DNLI
From Benzinga
4 Analysts Assess Denali Therapeutics: What You Need To Know
February 28, 2024
Tickers
DNLI
From Benzinga
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 27, 2024
From Benzinga
Norwegian Cruise Line Posts Strong Sales, Joins Hims & Hers Health, Sterling Infrastructure And Other Big Stocks Moving Higher On Tuesday
February 27, 2024
From Benzinga
Gene Therapy Player REGENXBIO's RGX-121 Marks Success In Trial, Yet Faces Challenges In A Crowded Market: Analyst
February 12, 2024
From Benzinga
3 Biotech Stocks to Buy for the Next Bull Run: February 2024
February 08, 2024
From InvestorPlace
3 Biotech Stocks at the Forefront of the Quest for Eternal Youth
January 02, 2024
From InvestorPlace
Expedia Group, Gartner, Cloudflare, Cardinal Health And Other Big Stocks Moving Higher On Friday
November 03, 2023
From Benzinga
Denali Therapeutics Breakthrough Blood-Brain Barrier Platform A Game-Changer in Neurodegenerative Diseases: Analyst
September 06, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023
September 06, 2023
From Benzinga
From InvestorPlace
Biogen and Denali Realign Parkinson's Disease Research Priorities Amidst R&D Restructure
June 05, 2023
From Benzinga
Denali Therapeutics Reveals New Interim Data From Early-Stage Hunter Syndrome Study
February 23, 2023
Tickers
DNLI
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
|
|
|